1. Acrolein: blocking antibody formation: pro tumor, anti‐allergy. (17th March 2014) Authors: Roth‐Walter, Franziska; Willensdorfer, Anna; Stremnitzer, Caroline; Schultz, Cornelia; Diesner, Susanne; Szalai, Krisztina; Fazekas, Judit; Moskovskich, Anna; Neunkirchner, Alina; Birnleitner, Hanna; Jensen‐Jarolim, Erika; Jensen‐Jarolim, Erika Journal: Clinical and translational allergy Issue: Volume 4:(2014)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prevention of allergy by virus‐like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model. Issue 2 (5th November 2018) Authors: Kratzer, Bernhard; Köhler, Cordula; Hofer, Sandra; Smole, Ursula; Trapin, Doris; Iturri, Jagoba; Pum, Dietmar; Kienzl, Philip; Elbe‐Bürger, Adelheid; Gattinger, Pia; Mittermann, Irene; Linhart, Birgit; Gadermaier, Gabriele; Jahn‐Schmid, Beatrice; Neunkirchner, Alina; Valenta, Rudolf; Pickl, Winfr... Journal: Allergy Issue: Volume 74:Issue 2(2019) Page Start: 246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. STAT3 governs hyporesponsiveness and granzyme B‐dependent suppressive capacity in human CD4+ T cells. Issue 3 (14th November 2014) Authors: Schmetterer, Klaus G.; Neunkirchner, Alina; Wojta‐Stremayr, Daniela; Leitner, Judith; Steinberger, Peter; Pickl, Winfried F. Journal: FASEB journal Issue: Volume 29:Issue 3(2015) Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗